The DOI matches its Crossref record; 196 of the 196 references it cites were found in a registry or an index.
A Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease
Open accessAbstract
Inflammatory bowel disease (IBD) is a chronic and life-threating inflammatory disease of gastroenteric tissue characterized by episodes of intestinal inflammation. The pathogenesis of IBD is complex. Recent studies have greatly improved our knowledge of the pathophysiology of IBD, leading to great advances in the treatment as well as diagnosis of IBD. In this review, we have systemically reviewed the pathogenesis of IBD and highlighted recent advances in host genetic factors, gut microbiota, and environmental factors and, especially, in abnormal innate and adaptive immune responses and their interactions, which may hold the keys to identify novel predictive or prognostic biomarkers and develop new therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Ng, S. C., Shi, H. Y., Hamidi, N., Underwood, F. E., Tang, W., Benchimol, E. I., Panaccione, R., Ghosh, S., Wu, J. C. Y., Chan, F. K. L., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32448-0 · Cited by 6,087
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Monocyte and macrophage heterogeneity
Gordon, S., & Taylor, P. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1733 · Cited by 5,190 · cited 2×
“Macrophages are differentiated from monocytes after emigrating from blood vessels in response to different stimuli [92, 93].”
BackgroundUnravelling the pathogenesis of inflammatory bowel disease
Xavier, R. J., & Podolsky, D. K. (2007) · Nature · doi:10.1038/nature06005 · Cited by 4,364
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251
Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species
Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., Cheng, G., Yamasaki, S., Saito, T., Ohba, Y., et al. (2011) · Science · doi:10.1126/science.1198469 · Cited by 3,752
The expanding universe of T-cell subsets: Th1, Th2 and more
Mosmann, T. R., & Sad, S. (1996) · Immunology Today · doi:10.1016/0167-5699(96)80606-2 · Cited by 3,633
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544
A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene
Duerr, R. H., Taylor, K. D., Brant, S. R., Rioux, J. D., Silverberg, M. S., Daly, M. J., Steinhart, A. H., Abraham, C., Regueiro, M., Griffiths, A., et al. (2006) · Science · doi:10.1126/science.1135245 · Cited by 3,039
Abraham, C., & Cho, J. H. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804647 · Cited by 2,712
Genetics and pathogenesis of inflammatory bowel disease
Khor, B., Gardet, A., & Xavier, R. J. (2011) · Nature · doi:10.1038/nature10209 · Cited by 2,614
Liu, J. Z., van Sommeren, S., Huang, H., Ng, S. C., Alberts, R., Takahashi, A., Ripke, S., Lee, J. C., Jostins, L., Shah, T., et al. (2015) · Nature Genetics · doi:10.1038/ng.3359 · Cited by 2,603
IDENTIFICATION OF A NOVEL CELL TYPE IN PERIPHERAL LYMPHOID ORGANS OF MICE
Steinman, R. M., & Cohn, Z. A. (1973) · The Journal of Experimental Medicine · doi:10.1084/jem.137.5.1142 · Cited by 2,424
The inhibitory cytokine IL-35 contributes to regulatory T-cell function
Collison, L. W., Workman, C. J., Kuo, T. T., Boyd, K., Wang, Y., Vignali, K. M., Cross, R., Sehy, D., Blumberg, R. S., & Vignali, D. A. A. (2007) · Nature · doi:10.1038/nature06306 · Cited by 2,066
Sun, C.-M., Hall, J. A., Blank, R. B., Bouladoux, N., Oukka, M., Mora, J. R., & Belkaid, Y. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070602 · Cited by 1,881
TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function
Zhou, L., Lopes, J. E., Chong, M. M. W., Ivanov, I. I., Min, R., Victora, G. D., Shen, Y., Du, J., Rubtsov, Y. P., Rudensky, A. Y., et al. (2008) · Nature · doi:10.1038/nature06878 · Cited by 1,863
Phenotypic and functional features of human Th17 cells
Annunziato, F., Cosmi, L., Santarlasci, V., Maggi, L., Liotta, F., Mazzinghi, B., Parente, E., Filì, L., Ferri, S., Frosali, F., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070663 · Cited by 1,861
Kaser, A., Zeissig, S., & Blumberg, R. S. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101225 · Cited by 1,806
Gut microbiota and IBD: causation or correlation?
Ni, J., Wu, G. D., Albenberg, L., & Tomov, V. T. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.88 · Cited by 1,778
The immunological and genetic basis of inflammatory bowel disease
Bouma, G., & Strober, W. (2003) · Nature Reviews Immunology · doi:10.1038/nri1132 · Cited by 1,767
Increased expression of interleukin 17 in inflammatory bowel disease
Fujino, S., Andoh, A., Bamba, S., Ogawa, A., Hata, K., Araki, Y., Bamba, T., & Fujiyama, Y. (2003) · Gut · doi:10.1136/gut.52.1.65 · Cited by 1,713
Hueber, W., Sands, B. E., Lewitzky, S., Vandemeulebroecke, M., Reinisch, W., Higgins, P. D. R., Wehkamp, J., Feagan, B. G., Yao, M. D., Karczewski, M., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301668 · Cited by 1,547
IL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6
Yen, D., Cheung, J., Scheerens, H., Poulet, F., McClanahan, T., Mckenzie, B., Kleinschek, M. A., Owyang, A., Mattson, J., Blumenschein, W., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci21404 · Cited by 1,542
Dendritic Cells: Unique Leukocyte Populations Which Control the Primary Immune Response
Hart, D. N. J. (1997) · Blood · doi:10.1182/blood.v90.9.3245 · Cited by 1,483
Gut microbiota in the pathogenesis of inflammatory bowel disease
Nishida, A., Inoue, R., Inatomi, O., Bamba, S., Naito, Y., & Andoh, A. (2018) · Clinical Journal of Gastroenterology · doi:10.1007/s12328-017-0813-5 · Cited by 1,377
The fundamental basis of inflammatory bowel disease
Strober, W., Fuss, I., & Mannon, P. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30587 · Cited by 1,319
Atreya, R., Mudter, J., Finotto, S., Müllberg, J., Jostock, T., Wirtz, S., Schütz, M., Bartsch, B., Holtmann, M., Becker, C., et al. (2000) · Nature Medicine · doi:10.1038/75068 · Cited by 1,293
HELLER, F., FLORIAN, P., BOJARSKI, C., RICHTER, J., CHRIST, M., HILLENBRAND, B., MANKERTZ, J., GITTER, A., BURGEL, N., & FROMM, M. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.002 · Cited by 1,230
Proinflammatory Cytokines in the Pathogenesis of Inflammatory Bowel Diseases
Strober, W., & Fuss, I. J. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.016 · Cited by 1,102
Natural and Adaptive Foxp3+ Regulatory T Cells: More of the Same or a Division of Labor?
Curotto de Lafaille, M. A., & Lafaille, J. J. (2009) · Immunity · doi:10.1016/j.immuni.2009.05.002 · Cited by 1,055
Inflammatory bowel disease: Epidemiology, pathogenesis, and therapeutic opportunities
Hanauer, S. B. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000195385.19268.68 · Cited by 968
Bain, C. C., Scott, C. L., Uronen-Hansson, H., Gudjonsson, S., Jansson, O., Grip, O., Guilliams, M., Malissen, B., Agace, W. W., & Mowat, A. M. (2013) · Mucosal Immunology · doi:10.1038/mi.2012.89 · Cited by 943
Smythies, L. E., Sellers, M. T., Clements, R. H., Mosteller‐Barnum, M., Meng, G., Benjamin, W. H., Orenstein, J. M., & Smith, P. D. (2005) · Journal of Clinical Investigation · doi:10.1172/jci19229 · Cited by 928
Cutting Edge: Cure of Colitis by CD4+CD25+ Regulatory T Cells
Mottet, C., Uhlig, H. H., & Powrie, F. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.8.3939 · Cited by 927
Proinflammatory Cytokines Disrupt Epithelial Barrier Function by Apoptosis-Independent Mechanisms
Bruewer, M., Luegering, A., Kucharzik, T., Parkos, C. A., Madara, J. L., Hopkins, A. M., & Nusrat, A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.6164 · Cited by 902
IL-35-mediated induction of a potent regulatory T cell population
Collison, L. W., Chaturvedi, V., Henderson, A. L., Giacomin, P. R., Guy, C., Bankoti, J., Finkelstein, D., Forbes, K., Workman, C. J., Brown, S. A., et al. (2010) · Nature Immunology · doi:10.1038/ni.1952 · Cited by 869
Colonic epithelial cell diversity in health and inflammatory bowel disease
Parikh, K., Antanaviciute, A., Fawkner-Corbett, D., Jagielowicz, M., Aulicino, A., Lagerholm, C., Davis, S., Kinchen, J., Chen, H. H., Alham, N. K., et al. (2019) · Nature · doi:10.1038/s41586-019-0992-y · Cited by 860
Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function
Condamine, T., & Gabrilovich, D. I. (2011) · Trends in Immunology · doi:10.1016/j.it.2010.10.002 · Cited by 845
Rimoldi, M., Chieppa, M., Salucci, V., Avogadri, F., Sonzogni, A., Sampietro, G. M., Nespoli, A., Viale, G., Allavena, P., & Rescigno, M. (2005) · Nature Immunology · doi:10.1038/ni1192 · Cited by 816
Fuss, I. J., Heller, F., Boirivant, M., Leon, F., Yoshida, M., Fichtner-Feigl, S., Yang, Z., Exley, M., Kitani, A., Blumberg, R. S., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19836 · Cited by 797
Regulation of inflammatory responses by IL-17F
Yang, X. O., Chang, S. H., Park, H., Nurieva, R., Shah, B., Acero, L., Wang, Y.-H., Schluns, K. S., Broaddus, R. R., Zhu, Z., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071978 · Cited by 739 · cited 1×
“IL-17F-deficiency improves the development of DSS-induced murine colitis, whereas IL-17-deficiency exaggerates the development of DSS-induced murine colitis, indicating that IL-17F rather than IL-17A is important in sustaining DSS colitis [171].”
BackgroundHuman CD25highFoxp3pos regulatory T cells differentiate into IL-17–producing cells
Koenen, H. J. P. M., Smeets, R. L., Vink, P. M., van Rijssen, E., Boots, A. M. H., & Joosten, I. (2008) · Blood · doi:10.1182/blood-2008-01-133967 · Cited by 736
Identification of IL-17-producing FOXP3+regulatory T cells in humans
Voo, K. S., Wang, Y.-H., Santori, F. R., Boggiano, C., Wang, Y.-H., Arima, K., Bover, L., Hanabuchi, S., Khalili, J., Marinova, E., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900408106 · Cited by 689
Th17: the third member of the effector T cell trilogy
Bettelli, E., Korn, T., & Kuchroo, V. K. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.07.020 · Cited by 652
Peripheral and Intestinal Regulatory CD4+CD25high T Cells in Inflammatory Bowel Disease
Maul, J., Loddenkemper, C., Mundt, P., Berg, E., Giese, T., Stallmach, A., Zeitz, M., & Duchmann, R. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.043 · Cited by 651
Heller, F., Fuss, I. J., Nieuwenhuis, E. E., Blumberg, R. S., & Strober, W. (2002) · Immunity · doi:10.1016/s1074-7613(02)00453-3 · Cited by 650
Fine-mapping inflammatory bowel disease loci to single-variant resolution
International Inflammatory Bowel Disease Genetics Consortium, Huang, H., Fang, M., Jostins, L., Umićević Mirkov, M., Boucher, G., Anderson, C. A., Andersen, V., Cleynen, I., Cortes, A., et al. (2017) · Nature · doi:10.1038/nature22969 · Cited by 611
Neurath, M. F., Weigmann, B., Finotto, S., Glickman, J., Nieuwenhuis, E., Iijima, H., Mizoguchi, A., Mizoguchi, E., Mudter, J., Galle, P. R., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011956 · Cited by 607
Kamada, N., Hisamatsu, T., Okamoto, S., Chinen, H., Kobayashi, T., Sato, T., Sakuraba, A., Kitazume, M. T., Sugita, A., Koganei, K., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34610 · Cited by 603
Peripheral CD4+ T‐cell differentiation regulated by networks of cytokines and transcription factors
Zhu, J., & Paul, W. E. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00951.x · Cited by 579
A comprehensive review and update on Crohn's disease
Gajendran, M., Loganathan, P., Catinella, A. P., & Hashash, J. G. (2018) · Disease-a-Month · doi:10.1016/j.disamonth.2017.07.001 · Cited by 550
Interleukin-23 Drives Intestinal Inflammation through Direct Activity on T Cells
Ahern, P. P., Schiering, C., Buonocore, S., McGeachy, M. J., Cua, D. J., Maloy, K. J., & Powrie, F. (2010) · Immunity · doi:10.1016/j.immuni.2010.08.010 · Cited by 528
IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells
Nusrat, A., Turner, J. R., & Madara, J. L. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.279.5.g851 · Cited by 497
Critical role of IL-17 receptor signaling in acute TNBS-induced colitis
Zhang, Z., Zheng, M., Bindas, J., Schwarzenberger, P., & Kolls, J. K. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000218764.06959.91 · Cited by 465
Characterization of Foxp3+CD4+CD25+ and IL-10-Secreting CD4+CD25+ T Cells during Cure of Colitis
Uhlig, H. H., Coombes, J., Mottet, C., Izcue, A., Thompson, C., Fanger, A., Tannapfel, A., Fontenot, J. D., Ramsdell, F., & Powrie, F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.5852 · Cited by 463
Monoclonal Anti–Interleukin 23 Reverses Active Colitis in a T Cell–Mediated Model in Mice
Elson, C. O., Cong, Y., Weaver, C. T., Schoeb, T. R., McClanahan, T. K., Fick, R. B., & Kastelein, R. A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.104 · Cited by 453
The unique role of natural killer T cells in the response to microorganisms
Tupin, E., Kinjo, Y., & Kronenberg, M. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1657 · Cited by 453
Gerlach, K., Hwang, Y., Nikolaev, A., Atreya, R., Dornhoff, H., Steiner, S., Lehr, H.-A., Wirtz, S., Vieth, M., Waisman, A., et al. (2014) · Nature Immunology · doi:10.1038/ni.2920 · Cited by 407
Richard, M. L., & Sokol, H. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0121-2 · Cited by 406
Myeloid derived suppressor cells in human diseases
Greten, T. F., Manns, M. P., & Korangy, F. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.01.003 · Cited by 398
The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models
Nell, S., Suerbaum, S., & Josenhans, C. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2403 · Cited by 398
Eastaff-Leung, N., Mabarrack, N., Barbour, A., Cummins, A., & Barry, S. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-009-9345-1 · Cited by 392
A Crohn’s disease variant in Atg16l1 enhances its degradation by caspase 3
Murthy, A., Li, Y., Peng, I., Reichelt, M., Katakam, A. K., Noubade, R., Roose-Girma, M., DeVoss, J., Diehl, L., Graham, R. R., et al. (2014) · Nature · doi:10.1038/nature13044 · Cited by 381
Differential regulation of interleukin 17 and interferon production in inflammatory bowel disease
Rovedatti, L., Kudo, T., Biancheri, P., Sarra, M., Knowles, C. H., Rampton, D. S., Corazza, G. R., Monteleone, G., Di Sabatino, A., & MacDonald, T. T. (2009) · Gut · doi:10.1136/gut.2009.182170 · Cited by 338
Dendritic cells in intestinal homeostasis and disease
Rescigno, M., & Di Sabatino, A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39134 · Cited by 327
Smith, P. D., Smythies, L. E., Mosteller-Barnum, M., Sibley, D. A., Russell, M. W., Merger, M., Sellers, M. T., Orenstein, J. M., Shimada, T., Graham, M. F., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.5.2651 · Cited by 326
Th9 cells: differentiation and disease
Kaplan, M. H. (2013) · Immunological Reviews · doi:10.1111/imr.12028 · Cited by 320
Myeloid-Derived Suppressor Cells in Inflammatory Bowel Disease: A New Immunoregulatory Pathway
Haile, L. A., von Wasielewski, R., Gamrekelashvili, J., Krüger, C., Bachmann, O., Westendorf, A. M., Buer, J., Liblau, R., Manns, M. P., Korangy, F., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.06.032 · Cited by 311
Evidence for continuous stimulation of interleukin-6 production in Crohn's disease
Gross, V., Andus, T., Caesar, I., Roth, M., & Schölmerich, J. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90098-j · Cited by 293
Ayyoub, M., Deknuydt, F., Raimbaud, I., Dousset, C., Leveque, L., Bioley, G., & Valmori, D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900621106 · Cited by 293
Urbanization and the gut microbiota in health and inflammatory bowel disease
Zuo, T., Kamm, M. A., Colombel, J.-F., & Ng, S. C. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0003-z · Cited by 293
Genetics and Pathogenesis of Inflammatory Bowel Disease
Liu, T.-C., & Stappenbeck, T. S. (2016) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044152 · Cited by 289
Biologic Therapy for Inflammatory Bowel Disease
Ardizzone, S., & Bianchi Porro, G. (2005) · Drugs · doi:10.2165/00003495-200565160-00002 · Cited by 280
Th17 plasticity and its relevance to inflammatory bowel disease
Ueno, A., Jeffery, L., Kobayashi, T., Hibi, T., Ghosh, S., & Jijon, H. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.12.004 · Cited by 266
Regulation of Gut Inflammation and Th17 Cell Response by Interleukin-21
Fina, D., Sarra, M., Fantini, M. C., Rizzo, A., Caruso, R., Caprioli, F., Stolfi, C., Cardolini, I., Dottori, M., Boirivant, M., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.041 · Cited by 265
A functional genomics predictive network model identifies regulators of inflammatory bowel disease
Peters, L. A., Perrigoue, J., Mortha, A., Iuga, A., Song, W.-M., Neiman, E. M., Llewellyn, S. R., Di Narzo, A., Kidd, B. A., Telesco, S. E., et al. (2017) · Nature Genetics · doi:10.1038/ng.3947 · Cited by 255
Takedatsu, H., Michelsen, K. S., Wei, B., Landers, C. J., Thomas, L. S., Dhall, D., Braun, J., & Targan, S. R. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.04.037 · Cited by 254
Recent understanding of IBD pathogenesis: Implications for future therapies
Kucharzik, T., Maaser, C., Lügering, A., Kagnoff, M., Mayer, L., Targan, S., & Domschke, W. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000235827.21778.d5 · Cited by 254
Sarra, M., Pallone, F., MacDonald, T. T., & Monteleone, G. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21248 · Cited by 249
The Role of Macrophages and Dendritic Cells in the Initiation of Inflammation in IBD
Steinbach, E. C., & Plevy, S. E. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e3182a69dca · Cited by 249
Yarur, A. J., Jain, A., Sussman, D. A., Barkin, J. S., Quintero, M. A., Princen, F., Kirkland, R., Deshpande, A. R., Singh, S., & Abreu, M. T. (2016) · Gut · doi:10.1136/gutjnl-2014-308099 · Cited by 242
The Immune Response in Inflammatory Bowel Disease
Brown, S. J., & Mayer, L. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01343.x · Cited by 237
Mucosal Macrophages in Intestinal Homeostasis and Inflammation
Mowat, A. M., & Bain, C. C. (2011) · Journal of Innate Immunity · doi:10.1159/000329099 · Cited by 234
Th1/Th17 Immune Response Is Induced by Mesenteric Lymph Node Dendritic Cells in Crohn's Disease
Sakuraba, A., Sato, T., Kamada, N., Kitazume, M., Sugita, A., & Hibi, T. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.07.049 · Cited by 230
Intestinal macrophages: unique effector cells of the innate immune system
Smith, P. D., Ochsenbauer‐Jambor, C., & Smythies, L. E. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00288.x · Cited by 228
Gambineri, E., Perroni, L., Passerini, L., Bianchi, L., Doglioni, C., Meschi, F., Bonfanti, R., Sznajer, Y., Tommasini, A., Lawitschka, A., et al. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.09.027 · Cited by 224
New Concepts in the Pathophysiology of Inflammatory Bowel Disease
Bamias, G., Nyce, M. R., De La Rue, S. A., & Cominelli, F. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-12-200512200-00007 · Cited by 221
TL1A–DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease
Pappu, B. P., Borodovsky, A., Zheng, T. S., Yang, X., Wu, P., Dong, X., Weng, S., Browning, B., Scott, M. L., Ma, L., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071364 · Cited by 218
Kamada, N., Hisamatsu, T., Okamoto, S., Sato, T., Matsuoka, K., Arai, K., Nakai, T., Hasegawa, A., Inoue, N., Watanabe, N., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6900 · Cited by 215
Identification of an Autophagy Defect in Smokers’ Alveolar Macrophages
Monick, M. M., Powers, L. S., Walters, K., Lovan, N., Zhang, M., Gerke, A., Hansdottir, S., & Hunninghake, G. W. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001603 · Cited by 214
NOD2, an intracellular innate immune sensor involved in host defense and Crohn's disease
Strober, W., & Watanabe, T. (2011) · Mucosal Immunology · doi:10.1038/mi.2011.29 · Cited by 214
Malmström, V., Shipton, D., Singh, B., Al-Shamkhani, A., Puklavec, M. J., Barclay, A. N., & Powrie, F. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6972 · Cited by 209
Evolving knowledge and therapy of inflammatory bowel disease
Korzenik, J. R., & Podolsky, D. K. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1986 · Cited by 208
Interleukin-35 Mediates Mucosal Immune Responses That Protect Against T-Cell–Dependent Colitis
Wirtz, S., Billmeier, U., Mchedlidze, T., Blumberg, R. S., & Neurath, M. F. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.040 · Cited by 207
Therapeutic targeting of myeloid-derived suppressor cells
Ugel, S., Delpozzo, F., Desantis, G., Papalini, F., Simonato, F., Sonda, N., Zilio, S., & Bronte, V. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.06.014 · Cited by 206
Characterization of FOXP3+CD4+ regulatory T cells in Crohn's disease
Saruta, M., Yu, Q. T., Fleshner, P. R., Mantel, P.-Y., Schmidt-Weber, C. B., Banham, A. H., & Papadakis, K. A. (2007) · Clinical Immunology · doi:10.1016/j.clim.2007.08.003 · Cited by 204
Cohen, L. J., Cho, J. H., Gevers, D., & Chu, H. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.03.017 · Cited by 201
Immunopathogenesis of inflammatory bowel disease
Shih, D. Q., & Targan, S. R. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.14.390 · Cited by 197
Kabat, A. M., Harrison, O. J., Riffelmacher, T., Moghaddam, A. E., Pearson, C. F., Laing, A., Abeler-Dörner, L., Forman, S. P., Grencis, R. K., Sattentau, Q., et al. (2016) · eLife · doi:10.7554/elife.12444 · Cited by 193
Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease
Kugathasan, S., Saubermann, L. J., Smith, L., Kou, D., Itoh, J., Binion, D. G., Levine, A. D., Blumberg, R. S., & Fiocchi, C. (2007) · Gut · doi:10.1136/gut.2006.116467 · Cited by 191
New pathophysiological insights and modern treatment of IBD
Engel, M. A., & Neurath, M. F. (2010) · Journal of Gastroenterology · doi:10.1007/s00535-010-0219-3 · Cited by 189
Mitsuyama, K., Toyonaga, A., Sasaki, E., Ishida, O., Ikeda, H., Tsuruta, O., Harada, K., Tateishi, H., Nishiyama, T., & Tanikawa, K. (1995) · Gut · doi:10.1136/gut.36.1.45 · Cited by 186
Recent Advances: The Imbalance of Cytokines in the Pathogenesis of Inflammatory Bowel Disease
Guan, Q., & Zhang, J. (2017) · Mediators of Inflammation · doi:10.1155/2017/4810258 · Cited by 182
Self-citationIL-9 and its receptor are predominantly involved in the pathogenesis of UC
Nalleweg, N., Chiriac, M. T., Podstawa, E., Lehmann, C., Rau, T. T., Atreya, R., Krauss, E., Hundorfean, G., Fichtner-Feigl, S., Hartmann, A., et al. (2015) · Gut · doi:10.1136/gutjnl-2013-305947 · Cited by 181
IL-1β and IL-2 convert human Treg into TH17 cells
Deknuydt, F., Bioley, G., Valmori, D., & Ayyoub, M. (2009) · Clinical Immunology · doi:10.1016/j.clim.2008.12.008 · Cited by 179
Smad7 Controls Resistance of Colitogenic T Cells to Regulatory T Cell-Mediated Suppression
Fantini, M. C., Rizzo, A., Fina, D., Caruso, R., Sarra, M., Stolfi, C., Becker, C., MacDonald, T. T., Pallone, F., Neurath, M. F., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.12.053 · Cited by 179
Experimental Inflammatory Bowel Disease: Insights into the Host-Microbiota Dialog
Saleh, M., & Elson, C. O. (2011) · Immunity · doi:10.1016/j.immuni.2011.03.008 · Cited by 178
Novel pathophysiological concepts of inflammatory bowel disease
Hibi, T., & Ogata, H. (2006) · Journal of Gastroenterology · doi:10.1007/s00535-005-1744-3 · Cited by 175
Genetics of inflammatory bowel disease: beyond NOD2
Mirkov, M. U., Verstockt, B., & Cleynen, I. (2017) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(16)30111-x · Cited by 171
Tajima, M., Wakita, D., Noguchi, D., Chamoto, K., Yue, Z., Fugo, K., Ishigame, H., Iwakura, Y., Kitamura, H., & Nishimura, T. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071133 · Cited by 166
Castellanos, J. G., Woo, V., Viladomiu, M., Putzel, G., Lima, S., Diehl, G. E., Marderstein, A. R., Gandara, J., Perez, A. R., Withers, D. R., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.10.014 · Cited by 161
Valmori, D., Raffin, C., Raimbaud, I., & Ayyoub, M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008247107 · Cited by 160
Kaser, A., & Blumberg, R. S. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.048 · Cited by 159
Hundorfean, G., Neurath, M. F., & Mudter, J. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21677 · Cited by 159
Himmel, M. E., Hardenberg, G., Piccirillo, C. A., Steiner, T. S., & Levings, M. K. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02939.x · Cited by 155
Retinoic acid-dependent regulation of immune responses by dendritic cells and macrophages
Manicassamy, S., & Pulendran, B. (2008) · Seminars in Immunology · doi:10.1016/j.smim.2008.07.007 · Cited by 155
The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation
Meylan, F., Song, Y.-J., Fuss, I. J., Villarreal, S., Kahle, E., Malm, I.-J., Acharya, K., Ramos, H. L., Lo, L., Mentink‐Kane, M. M., et al. (2010) · Mucosal Immunology · doi:10.1038/mi.2010.67 · Cited by 154
An Overview of the Innate and Adaptive Immune System in Inflammatory Bowel Disease
Choy, M. C., Visvanathan, K., & Cruz, P. P. D. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000955 · Cited by 152
Kusugami, K., Fukatsu, A., Tanimoto, M., Shinoda, M., Haruta, J.-I., Kuroiwa, A., Ina, K., Kanayama, K., Ando, T., Matsuura, T., et al. (1995) · Digestive Diseases and Sciences · doi:10.1007/bf02064182 · Cited by 151
Reinisch, W., Gasché, C., Tillinger, W., Wyatt, J., Lichtenberger, C., Willheim, M., Dejaco, C., Waldhör, T., Bakos, S., Vogelsang, H., et al. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01288.x · Cited by 150
Diet, gut microbes, and the pathogenesis of inflammatory bowel diseases
Dolan, K. T., & Chang, E. B. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600129 · Cited by 147
Gren, S. T., Janciauskiene, S. M., Uronen‐Hansson, H., Agace, W. W., Högerkorp, C., Spee, P., Håkansson, K., & Grip, O. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0113021 · Cited by 145
Velde, A. A. T., van Kooyk, Y., Braat, H., Hommes, D. W., Dellemijn, T. A. M., Slors, J. F. M., van Deventer, S. J. H., & Vyth‐Dreese, F. A. (2002) · European Journal of Immunology · doi:10.1002/immu.200390017 · Cited by 141
Comparison of experimental mouse models of inflammatory bowel disease
OH, S. Y., Cho, K., Kang, J. L., Kim, K. H., & Woo, S. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1569 · Cited by 132
Rugtveit, J., Bakka, A. O., & Brandtzaeg, P. (1997) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1997.5071404.x · Cited by 132
Rovedatti, L., Sabatino, A. D., Kudo, T., Biancheri, P., Sarra, M., Monteleone, G., Corazza, G. R., & MacDonald, T. T. (2009) · Digestive and Liver Disease · doi:10.1016/s1590-8658(09)60019-0 · Cited by 131
Kostovcikova, K., Coufal, S., Galanova, N., Fajstova, A., Hudcovic, T., Kostovcik, M., Prochazkova, P., Jiraskova Zakostelska, Z., Cermakova, M., Sediva, B., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00919 · Cited by 126
Kamada, N., Hisamatsu, T., Honda, H., Kobayashi, T., Chinen, H., Takayama, T., Kitazume, M. T., Okamoto, S., Koganei, K., Sugita, A., et al. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21124 · Cited by 124
Anti-TNF therapy: Safety aspects of taking the risk
Rosenblum, H., & Amital, H. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.04.010 · Cited by 120
Arora, M., Poe, S. L., Oriss, T. B., Krishnamoorthy, N., Yarlagadda, M., Wenzel, S. E., Billiar, T. R., Ray, A., & Ray, P. (2010) · Mucosal Immunology · doi:10.1038/mi.2010.41 · Cited by 119
Schleier, L., Wiendl, M., Heidbreder, K., Binder, M.-T., Atreya, R. N., Räth, T., Becker, E., Schulz-Kuhnt, A., Stahl, A., Schulze, L. L., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-316772 · Cited by 118
Wang, Y., Tian, J., Tang, X., Rui, K., Tian, X., Ma, J., Ma, B., Xu, H., Lu, L., & Wang, S. (2016) · Oncotarget · doi:10.18632/oncotarget.7324 · Cited by 116
Challenges in IBD Research: Environmental Triggers
Ho, S., Lewis, J. D., Mayer, E. A., Bernstein, C. N., Plevy, S. E., Chuang, E., Rappaport, S. M., Croitoru, K., Korzenik, J. R., Krischer, J. P., et al. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz076 · Cited by 116
Environmental Factors Affecting Inflammatory Bowel Disease: Have We Made Progress?
Lakatos, P. L. (2009) · Digestive Diseases · doi:10.1159/000228553 · Cited by 115
Ayyoub, M., Deknuydt, F., Raimbaud, I., Dousset, C., Leveque, L., Bioley, G., & Valmori, D. (2009) · The Journal of Immunology · Cited by 114
Permeability of human HT‐29/B6 colonic epithelium as a function of apoptosis
Bojarski, C., Gitter, A. H., Bendfeldt, K., Mankertz, J., Schmitz, H., Wagner, S., Fromm, M., & Schulzke, J. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.00541.x · Cited by 113
Colonic lamina propria dendritic cells in mice with CD4+ T cell‐induced colitis
Krajina, T., Leithäuser, F., Möller, P., Trobonjača, Z., & Reimann, J. (2003) · European Journal of Immunology · doi:10.1002/eji.200323518 · Cited by 111
New mediators of immunity and inflammation in inflammatory bowel disease
Monteleone, G., Fina, D., Caruso, R., & Pallone, F. (2006) · Current Opinion in Gastroenterology · doi:10.1097/01.mog.0000231808.10773.8e · Cited by 106
IBD-Associated TL1A Gene (TNFSF15) Haplotypes Determine Increased Expression of TL1A Protein
Michelsen, K. S., Thomas, L. S., Taylor, K. D., Yu, Q., Mei, L., Landers, C. J., Derkowski, C. A., McGovern, D. P. B., Rotter, J. I., & Targan, S. R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004719 · Cited by 104
Intestinal macrophages – specialised adaptation to a unique environment
Bain, C. C., & Mowat, A. M. (2011) · European Journal of Immunology · doi:10.1002/eji.201141714 · Cited by 103
Lytle, C. Y., Tod, T. J., Vo, K. T., Lee, J. W., Atkinson, R., & Straus, D. S. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000160805.46235.eb · Cited by 99
Role of Nod2 in the development of Crohn's disease
Yamamoto, S., & Ma, X. (2009) · Microbes and Infection · doi:10.1016/j.micinf.2009.06.005 · Cited by 96
The molecular basis of NOD2 susceptibility mutations in Crohn's disease
Strober, W., Kitani, A., Fuss, I. J., et al. (2008) · Mucosal Immunology · doi:10.1038/mi.2008.42 · Cited by 93
Szigethy, E., McLafferty, L. P., & Goyal, A. (2010) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2010.01.007 · Cited by 93
New cytokine therapeutics for inflammatory bowel disease
Stokkers, P. C. F., & Hommes, D. W. (2004) · Cytokine · doi:10.1016/j.cyto.2004.07.012 · Cited by 92
Magalhaes, J. G., Sorbara, M. T., Girardin, S. E., & Philpott, D. J. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.12.003 · Cited by 91
Cytokine Therapy for Crohn's Disease: Advances in Translational Research
Pizarro, T. T., & Cominelli, F. (2007) · Annual Review of Medicine · doi:10.1146/annurev.med.58.121205.100607 · Cited by 89
CD4+CD25+ Regulatory T Cells Suppress Th17-Responses in an Experimental Colitis Model
Ogino, H., Nakamura, K., Ihara, E., Akiho, H., & Takayanagi, R. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1286-2 · Cited by 87
New therapeutic strategies for treatment of inflammatory bowel disease
Atreya, R. N., & Neurath, M. F. (2008) · Mucosal Immunology · doi:10.1038/mi.2008.7 · Cited by 84
IL-9 regulates intestinal barrier function in experimental T cell-mediated colitis
Gerlach, K., McKenzie, A. N., Neurath, M. F., & Weigmann, B. (2015) · Tissue Barriers · doi:10.4161/21688370.2014.983777 · Cited by 83
Leithäuser, F., Trobonjača, Z., Möller, P., & Reimann, J. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780348 · Cited by 73
Kemseke, C. V., Bélaïche, J., & Louis, E. J. (2000) · International Journal of Colorectal Disease · doi:10.1007/s003840000226 · Cited by 72
Ng, S. C., Kamm, M. A., Stagg, A. J., & Knight, S. C. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21247 · Cited by 71
Meroni, E., Stakenborg, N., Viola, M. F., & Boeckxstaens, G. E. (2018) · Acta Physiologica · doi:10.1111/apha.13163 · Cited by 70
Deshane, J. S., Zmijewski, J. W., Luther, R. J., Gaggar, A., Deshane, R. J., Lai, J.-F., Xu, X., Spell, M. L., Estell, K., Weaver, C. T., et al. (2011) · Mucosal Immunology · doi:10.1038/mi.2011.16 · Cited by 69
Recent advances in cytokines: Therapeutic implications for inflammatory bowel diseases
Bouguen, G., Chevaux, J., & Peyrin‐Biroulet, L. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i5.547 · Cited by 65
Immunologic and Molecular Mechanisms in Inflammatory Bowel Disease
Ince, M. N., & Elliott, D. E. (2007) · Surgical Clinics of North America · doi:10.1016/j.suc.2007.03.005 · Cited by 62
Treatment of Crohn’s disease with anti-IL-6 receptor antibody
Ito, H. (2005) · Journal of Gastroenterology · doi:10.1007/bf02990576 · Cited by 62
Sun, R., Hedl, M., & Abraham, C. (2019) · Gut · doi:10.1136/gutjnl-2018-316830 · Cited by 61
Anti-TNF strategies in Crohn's disease: mechanisms, clinical effects, indications
Baert, F. J., & Rutgeerts, P. (1999) · International Journal of Colorectal Disease · doi:10.1007/s003840050182 · Cited by 60
Guan, Q., Moreno, S., Qing, G., Weiss, C. R., Lü, L., Bernstein, C. N., Warrington, R., Ma, Y., & Peng, Z. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0113050 · Cited by 60
Self-citationTumor Necrosis Factor Blockade for Treatment of Inflammatory Bowel Disease: Efficacy and Safety
Ngo, B., Farrell, C., Barr, M., Wolov, K., Bailey, R. J., Mullin, J. M., & Thornton, J. J. (2010) · Current Molecular Pharmacology · doi:10.2174/1874467211003030145 · Cited by 60
Inflammatory bowel disease—From mechanisms to treatment strategies
Melgar, S., & Shanahan, F. (2010) · Autoimmunity · doi:10.3109/08916931003674709 · Cited by 59
Regulation of intestinal homeostasis by dendritic cells
Tezuka, H., & Ohteki, T. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00872.x · Cited by 58
Targeting TGF-β1 by employing a vaccine ameliorates fibrosis in a mouse model of chronic colitis
Ma, Y., Guan, Q., Bai, A., Weiss, C. R., Hillman, C.-L., Ma, A., Zhou, G., Qing, G., & Peng, Z. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21167 · Cited by 55
Self-citationImmune and nonimmune components orchestrate the pathogenesis of inflammatory bowel disease
Danese, S. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00472.2010 · Cited by 54
Li, H., Song, J. M., Niu, G., Zhang, H., Guo, J., Shih, D. Q., Targan, S. R., & Zhang, X. (2017) · Pathology - Research and Practice · doi:10.1016/j.prp.2017.11.017 · Cited by 53
CD96 expression determines the inflammatory potential of IL-9–producing Th9 cells
Stanko, K., Iwert, C., Appelt, C., Vogt, K., Schumann, J., Strunk, F. J., Ahrlich, S., Schlickeiser, S., Romagnani, C., Jürchott, K., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1708329115 · Cited by 51
Mehta, M., Ahmed, S., & Dryden, G. W. (2017) · Innate Immunity · doi:10.1177/1753425917722206 · Cited by 50
Guan, Q., Ma, Y., Hillman, C.-L., Qing, G., Ma, A. G., Weiss, C. R., Zhou, G., Bai, A., Warrington, R., Bernstein, C. N., et al. (2011) · Molecular Medicine · doi:10.2119/molmed.2010.00252 · Cited by 49
Self-citationRoles of CD1d-restricted NKT cells in the intestine
van Dieren, J. M., van der Woude, J. C., Kuipers, E. J., et al. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20164 · Cited by 47
Kontaki, E., Boumpas, D. T., Tzardi, M. N., et al. (2017) · Autoimmunity · doi:10.1080/08916934.2017.1283405 · Cited by 47
Guan, Q., Blankstein, A. R., Anjos, K., Synova, O., Tulloch, M., Giftakis, A., Yang, B., Lambert, P. J., Peng, Z., Cuvelier, G. D. E., et al. (2015) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2015.04.015 · Cited by 46
Self-citationEnvironmental influences on T regulatory cells in inflammatory bowel disease
Hardenberg, G., Steiner, T. S., & Levings, M. K. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.01.012 · Cited by 46
Cytokines and growth factor modulators in intestinal inflammation and repair
Playford, R. J., & Ghosh, S. K. (2005) · The Journal of Pathology · doi:10.1002/path.1722 · Cited by 46
Richard, A. C., Peters, J. E., Yarkoni, N. S., Lee, J. C., Hawley, E., Meylan, F., Siegel, R. M., Lyons, P. A., & Smith, K. G. C. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007458 · Cited by 46
Salucci, V., Rimoldi, M., Penati, C., et al. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20390 · Cited by 38
Raffin, C., Raimbaud, I., Valmori, D., & Ayyoub, M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101742 · Cited by 38
MDSCs are involved in the protumorigenic potentials of GM-CSF in colitis-associated cancer
Ma, N., Liu, Q., Hou, L., Wang, Y., & Liu, Z. (2017) · International Journal of Immunopathology and Pharmacology · doi:10.1177/0394632017711055 · Cited by 35
Yang, M., Jia, W., Wang, D., Han, F., Niu, W., Zhang, H., Shih, D. Q., & Zhang, X. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05580-z · Cited by 33
Sidhu-Varma, M., Shih, D. Q., & Targan, S. R. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000653 · Cited by 28
Guan, Q., Ma, Y., Hillman, C.-L., Ma, A., Zhou, G., Qing, G., & Peng, Z. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.09.058 · Cited by 26
Self-citationGuan, Q., Ma, Y., Aboud, L. G., Weiss, C. R., Qing, G., Warrington, R., & Peng, Z. (2012) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2012.04022.x · Cited by 26
Self-citationGuan, Q., Weiss, C. R., Wang, S., Qing, G., Yang, X., Warrington, R., Bernstein, C. N., & Peng, Z. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy142 · Cited by 26
Self-citationMyeloid-Derived Suppressor Cells in Lung Transplantation
Heigl, T., Singh, A., Sáez, B., Kaes, J., Herck, A. V., Sacreas, A., Beeckmans, H., Vanstapel, A., Verleden, S. E., Raemdonck, D. E. V., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00900 · Cited by 26
Poh, T. W., Madsen, C. S., Gorman, J. E., Marler, R. J., Leighton, J. A., Cohen, P. A., & Gendler, S. J. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0278 · Cited by 25
Sawai, C. M., Serpas, L., Neto, A. G., Jang, G., Rashidfarrokhi, A., Kolbeck, R., Sanjuan, M. A., Reizis, B., & Sisirak, V. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02475 · Cited by 20
Phenotypic and Functional Diversities of Myeloid-Derived Suppressor Cells in Autoimmune Diseases
Ma, H., & Xia, C. (2018) · Mediators of Inflammation · doi:10.1155/2018/4316584 · Cited by 20
TL1A modulates the severity of colitis by promoting Th9 differentiation and IL-9 secretion
Wang, D., Li, H., Duan, Y.-Y., Han, F., Luo, Y., Mengyao, W., Yang, M.-Y., Zhan, R., Song, J. M., Zhang, H., et al. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.06.011 · Cited by 20
Zhou, G. Q., Ma, Y., Jia, P., Guan, Q., Uzonna, J. E., & Peng, Z. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.11.081 · Cited by 14
Self-citationAntibody‐Mediated Antigen Sampling across Intestinal Epithelial Barriers
Berin, M. C., Li, H., & Sperber, K. E. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1326.002 · Cited by 14
Employing an IL-23 p19 Vaccine to Block IL-23 Ameliorates Chronic Murine Colitis
Guan, Q., Burtnick, H. A., Qing, G., Weiss, C. R., Ma, A. G., Ma, Y., Warrington, R., & Peng, Z. (2013) · Immunotherapy · doi:10.2217/imt.13.141 · Cited by 12
Self-citationGuan, Q., Warrington, R., Moreno, S., Qing, G., Weiss, C. R., & Peng, Z. (2019) · Future Science OA · doi:10.2144/fsoa-2018-0125 · Cited by 6
Self-citation
Cited by
Wang, R., Li, Z., Liu, S., & Zhang, D. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-065186 · Cited by 597
CD38: An Immunomodulatory Molecule in Inflammation and Autoimmunity
Piedra-Quintero, Z. L., Wilson, Z., Nava, P., & Guerau-de-Arellano, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.597959 · Cited by 332
Chen, Y., Cui, W., Li, X., & Yang, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.761981 · Cited by 271
Neuroinflammation as an etiological trigger for depression comorbid with inflammatory bowel disease
Craig, C. F., Filippone, R. T., Stavely, R., Bornstein, J. C., Apostolopoulos, V., & Nurgali, K. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02354-1 · Cited by 124
Valdés-Mas, R., Leshem, A., Zheng, D., Cohen, Y., Kern, L., Zmora, N., He, Y., Katina, C., Eliyahu-Miller, S., Yosef-Hevroni, T., et al. (2025) · Cell · doi:10.1016/j.cell.2024.12.016 · Cited by 89
Metadata
- Authors
- Guan, Q.
- Venue
- Journal of Immunology Research
- Publisher
- Wiley
- Published
- 2019-12-01
- Volume
- 2019
- Pages
- 1-16
- ISSN
- 2314-7156 (ISSN-L)
- 2314-8861
- OpenAlex
- W2991550463
- Cited by
- 1,065
- References
- 196
- FWCI
- 43.88
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.